Author: Qibin Liu; Xuemin Fang; Shinichi Tokuno; Ungil Chung; Xianxiang Chen; Xiyong Dai; Xiaoyu Liu; Feng Xu; Bing Wang; Peng Peng
Title: Prediction of the clinical outcome of COVID-19 patients using T lymphocyte subsets with 340 cases from Wuhan, China: a retrospective cohort study and a web visualization tool Document date: 2020_4_11
ID: 125o0o7x_1
Snippet: 2020 received treatment according to the fifth edition of the Ministry of Health guidelines [8] [9] : 1. Bed rest and supportive treatment; 2. Regular examination on blood routine, CRP, biochemistry, coagulation function, myocardial enzymes, lung CT; 3. Oxygen therapy, including nasal catheter oxygen, transposal high-flow oxygen therapy, ventilator; 4. Antiviral therapy, including Lopinavir/Ritonavir tablets, Arbidol Hydrochloride Tablets, etc. I.....
Document: 2020 received treatment according to the fifth edition of the Ministry of Health guidelines [8] [9] : 1. Bed rest and supportive treatment; 2. Regular examination on blood routine, CRP, biochemistry, coagulation function, myocardial enzymes, lung CT; 3. Oxygen therapy, including nasal catheter oxygen, transposal high-flow oxygen therapy, ventilator; 4. Antiviral therapy, including Lopinavir/Ritonavir tablets, Arbidol Hydrochloride Tablets, etc. If the patient maintained a normal body temperature for at least three days, and tested negative with COVID-19 (including throat swab, stool, and sputum) at least twice and 24+ hours apart, as well as showing significant improvement in lung CT, the patient would be considered recovered and discharged from the hospital. The discharged patients were transported by the Chinese government using designated vehicles and they were further isolated for at least two weeks.
Search related documents:
Co phrase search for related documents- antiviral therapy and body temperature: 1, 2, 3, 4, 5, 6
- antiviral therapy and coagulation function: 1, 2
- antiviral therapy and discharged patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- antiviral therapy and high flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral therapy and high flow oxygen therapy: 1, 2, 3, 4, 5, 6, 7
- antiviral therapy and hospital discharge: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy and Lopinavir Ritonavir tablet: 1
- antiviral therapy and negative test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antiviral therapy and normal body temperature: 1
- antiviral therapy and oxygen therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62
- antiviral therapy and significant improvement: 1, 2, 3, 4, 5, 6, 7
- antiviral therapy and sputum stool: 1, 2
- antiviral therapy and supportive treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- antiviral therapy and treatment receive: 1, 2, 3
- bed rest and blood routine: 1
- bed rest and coagulation function: 1
- bed rest and high flow: 1
- bed rest and high flow oxygen therapy: 1
- bed rest and hospital discharge: 1, 2
Co phrase search for related documents, hyperlinks ordered by date